Small Lung Tumours: High Risk Lesions and Contraindications to Stereotactic Ablative Body Radiotherapy (SABR)

被引：0
|
作者：
Ball, D. [1 ]
机构：
[1] Peter MacCallum Canc Ctr, Radiat Oncol, Melbourne, Vic, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
Stereotactic ablative radiotherapy; contraindications;
D O I：
10.1016/j.jtho.2018.08.080
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MTE24.02
引用
收藏
页码：S225 / S226
页数：2
相关论文
共 50 条
  • [41] Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer
    Abbas, Ghulam
    Danish, Adnan
    Krasna, Mark J.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 25 (03) : 553 - +
  • [42] Stereotactic body radiotherapy for central lung tumours
    Dahele, M.
    Tekatli, H.
    Senan, S.
    BRITISH JOURNAL OF RADIOLOGY, 2015, 88 (1053):
  • [43] Stereotactic Ablative Radiotherapy (SABR) For Oligometastases: Risk Stratification Using Positional Uncertainty
    Zhang, T.
    Clark, H.
    Thomas, S.
    Olson, R. A.
    Ma, R.
    Schellenberg, D.
    Tyldesley, S.
    Palma, D. A.
    Liu, M. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E180 - E181
  • [44] Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma
    Byung-Han Rhieu
    Amol K. Narang
    Jeffrey Meyer
    Current Hepatology Reports, 2018, 17 (4) : 392 - 398
  • [45] STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) FOR OLIGOMETASTASES: RISK STRATIFICATION USING POSITIONAL UNCERTAINTY
    Zhang, Tina
    Clark, Haley
    Thomas, Steven
    Olson, Robert
    Ma, Roy
    Schellenberg, Devin
    Palma, David
    Liu, Mitchell
    RADIOTHERAPY AND ONCOLOGY, 2020, 150 : S85 - S86
  • [46] Stereotactic Ablative Radiotherapy (SABR) for Pulmonary Oligometastases and Oligoprogression
    Helou, Joelle
    Thibault, Isabelle
    Yeung, Latifa L.
    Poon, Ian
    Tjong, Michael
    Chiang, Andrew
    Jain, Suneil
    Soliman, Hany
    Cheung, Patrick
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S636 - S636
  • [47] Outcome of stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer (NSCLC)
    Islam, Mohammad
    Cyriac, Abby
    Durga, Tarun
    Sarkodie, Thomas
    Begum, Gulshad
    Evans, Joanne
    Palvai, Sreekanth
    Tun, Khin
    LUNG CANCER, 2023, 178 : S55 - S55
  • [48] Audit of radiotherapy plan quality for stereotactic ablative radiotherapy (SABR) for stage 1 non-small cell lung cancer
    Pascoe, A. C.
    Foweraker, K.
    Esler, C.
    Morgan, S.
    Wallace, A.
    Launders, D.
    Harron, E.
    CLINICAL ONCOLOGY, 2016, 28 : S4 - S4
  • [49] Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach
    Agolli, Linda
    Valeriani, Maurizio
    Nicosia, Luca
    Bracci, Stefano
    De Sanctis, Vitaliana
    Minniti, Giuseppe
    Enrici, Riccardo Maurizi
    Osti, Mattia Falchetto
    ANTICANCER RESEARCH, 2015, 35 (11) : 6239 - 6245
  • [50] Stereotactic ablative body radiotherapy (SABR) for the radical treatment of early lung cancer: initial outcomes from the Southwest Peninsula regional SABR MDT
    Cope, Victoria
    Goranov, Bojidar
    Eleanor, Weir
    Park, Sarah
    Richters, Megan
    Kingdon, Sarah
    Gordon, Tanya
    Rangegowda, Sanjay
    Aldridge, Robin
    Ford, Victoria
    LUNG CANCER, 2025, 200
12345